MONDAY, OCTOBER 23, 2017

CMC Biologics, PATH partner to speed monoclonal antibodies development

CMC Biologics, a worldwide leader in commercial and clinical development and contract manufacturer of therapeutic proteins, recently announced a new agreement with PATH Malaria Vaccine Initiative (MVI) to create and produce malaria-specific monoclonal antibodies against malaria infections. Read More »

Scientists build atomic model of immature retrovirus

Scientists recently used molecular modeling as well as large-scale molecular dynamic simulation to build an immature retrovirus in the form of an atomic model. Read More »

Many youth with HIV may be susceptible to measles, mumps and rubella

The National Institutes of Health recently collaborated with the Centers for Disease Control and Prevention to report that the majority of youth who have HIV infections may have inadequate immunity against measles, mumps and rubella despite receiving vaccinations. Read More »

New Mexico officials confirm third human case of tularemia

The New Mexico Department of Health recently confirmed that there has been a new human case of tularemia. Read More »

Walgreens among pharmacies to provide flu vaccines

Walgreens, Healthcare Clinics and Duane Reade pharmacies recently announced that they will provide flu vaccinations on a daily basis without the need to schedule an appointment. Read More »

West Nile virus death confirmed in Washington state

The state of Washington recently confirmed its first resident to die from West Nile virus for 2015. Read More »

Epstein-Barr virus vaccine shows promise in animal study

A team of scientists from the National Institute of Allergy and Infectious Diseases, a branch of the National Institutes of Health, have created an experimental, nanoparticle-based vaccine for Epstein-Barr virus (EBV) that has successfully provoked potent neutralizing antibodies in mice and nonhuman primates. Read More »

Combination vaccine may decrease number of required vaccines for infants

A new combination vaccine that recently went through a phase III trial may help to decrease the number of immunizations that are mandated for infants and toddlers in order to keep them updated according to the standards set by the U.S. infant immunization schedule. Read More »

Research shows why children with malaria often develop deadly blood cancer

A team of scientists from Rockefeller University recently conducted research to explain how malaria infections can increase the chances that a child will develop a deadly, aggressive blood cancer called Burkitt’s lymphoma. Read More »

Researchers create largest genomic data set for Lassa virus

A team of researchers from around the world have created the biggest genomic data set for Lassa virus (LASV) in the world. Read More »

Improved methods for engineering therapeutic proteins into antibodies

A team of researchers from The Scripps Research Institute (TSRI) recently created a better way to engineer therapeutic proteins in antibodies, which would allow antibodies to persist against invading bacteria and viruses for longer periods of time. Read More »

South Sudan could potentially experience severe malaria season this year

Notable increases in malaria throughout South Sudan have health professionals concerned whether there will be a second season in a row of unusually high malaria case numbers. Read More »

Study shows Ontario near UN targets to end AIDS epidemic

People with HIV in Canadian province are being well cared for, but gaps still exist for young gay men Read More »

Indiana confirms three E. coli cases out of six ill people, with one death

The Indiana State Department of Health (ISDH) confirmed three E. coli O157:H7 cases in three northern Indiana counties late last week. A total of six people with diarrheal illnesses currently are under investigation, one of whom has died. Read More »

Vaxart to present at Euro Global Summit on Vaccines

Vaxart Inc., a clinical-stage, privately held company that creates vaccines for delivery to patients through tablets instead of injections, recently announced that it will give a presentation at the sixth Euro Global Summit and Expo on Vaccines and Vaccination. Read More »

Last Ebola virus transmission chain announced in Sierra Leone

Health professionals recently announced that an entire epidemiological week has passed without any new Ebola cases in Sierra Leone, which is the first time this has happened since the beginning of the Ebola outbreak. Read More »

CaroGen unveils research for hepatitis B therapeutic vaccine technology

CaroGen Corporation, an emerging vaccine company, recently announced that it has electronically published information about its research for therapeutic vaccine technology, specifically for the hepatitis B virus. Read More »

PharmaSecure launches second phase of TB control program in India

PharmaSecure, a worldwide leader in providing customer engagement and brand protection solutions, recently launched the second phase of the “Grand Challenges in TB Control” grant program that is taking place in India. Read More »

Alterra raises funds to fight Malaria

Alterra has joined the United Nations Foundation "Nothing But Nets" to fight against malaria by raising $105,359 in donations over the course of approximately one year. Read More »

Number of wild polio cases declining internationally

WHO: Number of cases have fallen off significantly, but threat still remains. Read More »